Gene Query: ARFIP2

Dataset Description Geneva Score
Convergent exaptation of Alu and B/ID SINEs for Staufen-mediated mRNA decay 30.77
Gene expression in PANC1 cells treated with Rakicidin 20.97
TCF7L1 knockdown in pancreatic cancer 19.19
Next Generation Sequencing Facilitates Quantitative Analysis of miR-29b-1 and miR-29a targets in tamoxifen-sensitive and tamoxifen-resistant human breast cancer cells 18.22
Transcriptome-wide identification of splicing defects upon XAB2 knockdown 17.61
Expression changes in melanoma cell lines under BRAFi treatment timepoints [RNA-Seq.CellLine.batch4] 17.09
Supraphysiological Androgens Repress Prostate Cancer Growth and Induce DNA Damage Augmented by PARP Inhibition 16.94
Role for the Transcriptional Activator ZRF1 in Breast Cancer Progression and Endocrine Resistance 16.39
Cell differentiation grade determines distinct FOXA2 contributions to the cis-regulatory networks of pancreatic cancer cells [RNA-seq] 15.64
Cell differentiation grade determines distinct FOXA2 contributions to the cis-regulatory networks of pancreatic cancer cells 15.64
The X-linked DDX3X RNA helicase dictates translation re-programming and metastasis in melanoma 14.96
Genome wide transcriptome analysis of palbociclib or GSK3326595 treated A375 cells [Palbociclib_GSK_RNASeq] 14.7
A common cell state in Triple Negative Breast Cancers represents a druggable vulnerability 13.95
Tumors with TSC mutations are sensitive to CDK7 inhibition through NRF2 and glutathione depletion 13.55
RNAseq Study in CC-671 Treated Cal-51 Cells 13.51
Ultracentifugation and nanoscale deterministic lateral displacement (nanoDLD) of samples for exRNA analysis 13.33
Expression analysis of genes modulated after knock-down of lncRNA CHROME. 13.28
Global transcriptional changes in U87MG glioblastoma cells upon shRNA-mediated TRIM52 knockdown 13.04
ChIP-seq and RNA-seq in BGC823 cells after downregulation of GAS1 expression 12.77
A novel lncRNA GAS1 promotes gastric carcinogenesis and acts as a modular scaffold of WDR5 and KAT2A complexes to specify the histone modification pattern [RNA-seq] 12.77
Interactions of aCPs with Cytosine-rich Polypyrimidine Tracts Enhance Splicing of Cassette Exons 12.65
Gene expression by high-throughput sequencing of T47D-MTVL human breast cancer cells upon H1.4 knock-down and multiple H1 variants 12.29
Integrative Analysis of Tamoxifen-resistant Cell Line Models Based on Sequencing Genomes, Transcriptomes and Epigenomes [seq] 12.2
Integrative Analysis of Tamoxifen-resistant Cell Line Models Based on Sequencing Genomes, Transcriptomes and Epigenomes 12.2
Dtx3L and Androgen Signaling in Prostate Cancer 12.15
miRNA-1343 attenuates pathways of fibrosis by targeting the TGF-beta receptors [RNA-seq] 12.04
Effect of Hotair overexpression in human breast cancer cell lines 11.64
RNA-Seq analysis of cSCC cells after siRNA-induced gene knockdown of lncRNA PRECSIT 11.04
XBP1s Activation Globally Remodels N-Glycan Structure Distribution Patterns 10.96
G-quadruplex structures mark human regulatory chromatin 10.92
Transcriptome analysis on TDP43 and SRSF3 downstream genes and binding RNAs in MDA-MB231 cells by Next Generation Sequencing 10.6
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export II 10.57
Gene-Centric Functional Dissection of Human Genetic Variation Uncovers Regulators of Hematopoiesis 10.5
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [K562] 9.7
Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer. 9.69
Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer. 9.69
SIRT6 regulates redox homeostasis in human mesenchymal stem cells by the transactivation of NRF2 9.64
Paxillin regulates genomic networks in prostate cancer [C4-2] 9.6
Enhancing human kidney organoid differentiation from pluripotent stem cells with high-throughput automation 9.47
Ribosome profiling of A549 cells depleted of RPLP1 and RPLP2 and infected with DENV. 9.15
Direct identification of endogenous SMG6 targets and a preferred motif spanning SMG6 cleavage sites by parallel analysis of RNA ends in human cells 8.99
Role for citron kinase in prostate cancer growth 8.98
Waterpipe Smoking Induces Epigenetic Changes in the Small Airway Epithelium 8.91
Waterpipe Smoking Induces Epigenetic Changes in the Small Airway Epithelium [RNA-Seq] 8.91
RNA sequence of mRNA in HUVEC cells after depleting EGFL6 8.71
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and AXL-/- astrocytes Transcriptomes 8.65
Gene expression profiles in response to proanthocyanidins in pancreatic cancer cells 8.54
Effect of BB608 on Gene Expression in HNSCC Cell Line 8.48
Integrative transcriptome-wide analyses reveal critical HER2-regulated mRNAs and lincRNAs in HER2+ breast cancer 8.42
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [BAA] 8.23
TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells [RNA-seq] 8.22
TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells 8.22
RNA Seq of HMVEC under hypoxia 8.12
Endothelial-AGO1-knockout (EC-AGO1-KO) mice and wild-type (WT) littermates 8.12
Function of HNRNPC in breast cancer cells by controlling the dsRNA-induced interferon response 8.01
Estrogen receptor and mTOR signaling rewires cancer metabolism in obesity-associated breast cancer 8.0
Silencing p300 in MCF7 cells to study expression and alternative splicing 7.94
Leukodystrophy-associated POLR3A mutations down-regulate the RNA polymerase III transcript and important regulatory RNA BC200 7.87
Discovery of cis-spliced chimeric RNAs between adjacent genes in human prostate cells 7.74
An Argonaute phosphorylation cycle promotes microRNA-mediated silencing [polyA RNA-seq] 7.74
Transcriptome sequencing of human coronary artery smooth muscle cell under treatment of nitrated fatty acid 7.71
Luminal lncRNAs Regulation by ERα-controlled Enhancers in a Ligand-independent Manner in Breast Cancer Cells 7.67
Modeling and characterization of the dynamic gene regulatory networks underlying cancer drug resistance based on time-course RNA-seq data 7.64
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression (nuclear RNA) 7.59
Effect of hypoxia and TGFβ1 on gene expression in HPF fibroblast cells 7.5
Exploiting drug addiction mechanisms to select against MAPKi resistant melanoma 7.47
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival 7.42
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival [RNA-Seq] 7.42
mRNA profiling reveals determinants of trastuzumab efficiency in HER2-positive breast cancer 7.39
Understanding the Mechanistic Contribution of Herbal Extracts in Compound Kushen Injection with Transcriptome Analysis 7.38
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc 7.38
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc [RNA-Seq] 7.38
Effect of hyperfractionated irradiation (HFRT) of prostate primary basal cells (PrEPs) on the transcriptome 7.34
Mitochondrial dsRNA triggers antiviral signalling in humans 7.34
Detection of internal N7-methylguanosine (m7G) RNA modifications by mutational profiling sequencing 7.27
hnRNP C is a key regulator of protein synthesis in mitosis 7.25
Transcriptome-wide identification of CELF2 functional targets in T cells 7.24
Next-generation sequencing analysis of transcriptom in gemcitabine resistant pancreatic cancer cells 7.22
Identification of a core p53 transcriptional program with highly fractionated tumor suppressive activity 7.19
GRO-seq from HCT116, MCF7 and SJSA cell lines treated with DMSO and Nutlin 7.19
mRNA Sequencing of Human PromoCells Using Random Primed mRNA-Sequencing Technique 7.17
Gene expression analysis of the impact of TDP-43 knockout in human cells. 7.15
Gene expression changes in human melanoma cell lines compared to primary melanocytes 7.15
Quantitative Analysis of PPARD Transcriptomes in Colon Cancer Cells by Next Generation Sequencing (NGS) 7.13
snRNAs as regulators of alternative splicing 7.07
Identification of differential expressed genes of JQ1 or JQ1+Bortezomib in colorectal cancer cells 7.04
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer (RNA-Seq) 6.98
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer 6.98
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition (RNA-seq) 6.89
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition 6.89
Gene expression and 4sUDRB-seq for NF90/NF110 of human scramble and KD HeLa cells. 6.89
Cajal bodies are linked to genome conformation 6.84
Cajal bodies are linked to genome conformation [RNA-Seq] 6.84
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function 6.83
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function [Rnase-Seq] 6.83
Analysis of transcriptome changes following SOX2 knockdown in three different Ewing sarcoma cell lines 6.82
Cell-specific expression and function patterns of microRNA-150-5p in liver fibrogenesis 6.75
Apatinib preferentially inhibits Gefitinib-resistant lung cancer cells by inducing cell cycle arrest and inhibiting VEGFR signaling pathway 6.74
Base-resolution mapping reveals distinct classes of N1-methyladenosine methylome in nuclear- and mitochondrial-encoded transcripts 6.67
Gene expression profile in breast cancer cell lines using RNA sequencing 6.66
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes [RNA-Seq] 6.64
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes 6.64
Human Adipocytes Regulate Gene Expression in Triple-negative Breast Cancer Assessed by NGS Sequencing 6.63
Inhibition of TNBC metastasis by Gpx1 6.59
RNA-Seq analysis of primary human keratinocytes exposed to Cannabidiol 6.55
RNAseq analysis of patient-derived luminal breast cancer xenografts treated with progestins 6.55
Patient-derived luminal breast cancer xenografts with progestins 6.55
Circular RNAs are down-regulated in KRAS mutant colon cancer cells and can be transferred to exosomes 6.55
Transcriptome analysis of A549 cells expressing a SUMOylation-deficient TRIM28 mutant in the context of influenza A virus infection 6.53
PTBP1 excludes UPF1 to protect long 3'UTRs from nonsense-mediated mRNA decay 6.52
Multiple roles for Grainyheadlike transcription factors in the establishment and maintenance of human mucociliary airway epithelium 6.46
Gene Expression of Breast Cancer Cell Lines Across Biomaterial Platforms 6.42
Heterogeneous nuclear ribonucleoprotein C1/C2 links transcriptional and splicing actions of 1,25-dihydroxyvitamin D 6.36
Transcriptional control of subtype switching ensures adaptation and growth of pancreatic cancer 6.36
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 6.32
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 (RNA-Seq) 6.32
Ets homologous factor has critical roles in epithelial dysfunction in airway disease [RNA-seq] 6.31
Ets homologous factor has critical roles in epithelial dysfunction in airway disease 6.31
Next-generation sequencing of human dermal fibroblasts transdifferentiated towards the otic lineage 6.31
Functional interactions between Mi-2β and AP1 complexes control response and recovery from barrier disruption 6.3
Profiling of protrusion-enriched RNAs from human breast cancer cell line MDA-MB-231 6.29
Transcriptional profiling of JEG3 cells with HLA-G ablation via deletion of Enhancer L 6.26
Meta-organization of Translation Centers Revealed by Proximity Mapping of Endoplasmic Reticulum Ribosome Interactors 6.22
Determining effects of microbial metabolite, Urolithin A on colon epithelial cells 6.18
MenSCs inhibit HCC growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements 6.16
MenSCs inhibit HCC growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements [RNA-seq] 6.16
Molecular Biomarkers Screened by Next-generation RNA Sequencing for non-sentinel lymph node status predicting in breast cancer patients with metastatic sentinel lymph node 6.15
Characterization of human CDK12 and CDK13 in the regulation of RNA processing 6.09
Effects of Cardiac Glycosides on RNA Expression in Prostate Cancer LNCaP-abl Cells 6.05
Long non-coding RNA TYKRIL controls pericyte function and survival in the cardiovascular and central nervous system through regulation of p53 activity and PDGFRß expression 6.03
Genome-wide expression change by SHARPIN knockdown in MCF-7 cells 5.98
Identification of miR-100 and miR-125b targets by AGO2 RIP-seq and RNA-seq after ectopic expression of miR-100 or miR-125b and evaluation of the TGFb expression signature in PANC-1 cells by RNA-seq 5.97
Identification of global XBP1s target gene expression in human prostate cancer cells 5.96
Systems-level analyses reveal a convergent pathway for progression of diffuse astrocytoma and potential role for resveratrol in delaying high-grade transformation 5.95
Presence of NAD+-capped RNA in human cells: function and removal by the DXO deNADing Protein 5.95
FMRP-associated MOV10 facilitates and antagonizes miRNA-mediated regulation 5.93
Genetic disruption of COX-1 inhibits multiple oncogenic pathways 5.91
Binding to SMN2 pre-mRNA-Protein complex elicits specificity for small molecule splicing modifiers 5.9
TGF-β regulation of miRNA expression in pancreatic cancer 5.89
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer [RNA-seq] 5.86
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer 5.86
The Wnt/β-catenin-signaling pathway is modulated by androgen ablation therapy for advanced clinical prostate cancer and contributes to androgen independent cell growth 5.84
Exogenous pyruvate represses histone gene expression to inhibit cancer cell proliferation via the NAMPT-NAD + -SIRT1 pathway 5.82
Sequencing of freshly produced RNA following exposure of cells to DNA damage-inducing UV mimetic 4-hydroxyaminoquinolone (4-NQO) 5.79
Analysis of transcriptional regulation by Myt1 and Myt1l 5.75
Exploring the gene expression profile upon FXR1 knockdown in H358 cells using RNA-seq 5.73
RNA-seq analysis of HT-29, MCF10A, and MDA-MB-436 cells 5.72
RNA expression following TMPRSS11B overexpression or depletion 5.72
Gene expression changes caused by KRAS in MCF-10A 5.66
R430: A potent inbibitor of DNA and RNA viruses 5.65
Effect of CTCF and Rad21 knockdown on SLK cells and KSHV gene expression 5.63
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator [RNA-seq] 5.63
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator 5.63
Multiple mechanisms disrupt let-7 miRNA biogenesis and function in neuroblastoma [longRNA] 5.6
Analysis of HPV16 E2 host gene expression using TERT immortalized keratinocytes (NOKs) cell lines and RNA-sequencing 5.59
STVI-120 Induction of differentiation in human epidermal stem cells followed by differential splicing analysis 5.58
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation [RNA-Seq] 5.58
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation 5.58
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription [RNA-Seq1] 5.56
T47D RNA-seq and ChrRNA-seq data 5.53
Arginine citrullination at the C-terminal domain controls RNA Polymerase II transcription 5.53
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex (RNA-Seq I) 5.53
SUV420H2 knockdown in PANC-1 5.52
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer (RNA-seq) 5.45
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer 5.45
ER proteostasis and temperature differentially impact the mutational tolerance of influenza hemagglutinin 5.42
CREB5 promotes resistance to androgen-receptor antagonists and androgen deprivation in prostate cancer 5.42
Viral determinants in H5N1 influenza A virus enable productive infection of HeLa cells 5.4
ATF4 inhibition by p62 represses stromal metabolic reprogramming and tumorigenesis II 5.4
Evolution of an lncRNA leads to a primate specific modulation of alternative splicing 5.38
RNA-sequencing WT vs SOCS3 knockout Glioblastoma stem-cells 5.33
Metabolic Reprogramming Associated with Aggressiveness Occurs in the G-CIMP-High Molecular Subtypes of IDH1mut Lower Grade Gliomas 5.3
RNA sequencing of BT142 and TS603 cell lines 5.3
Whole Transcriptome RNASeq Data for Cell-Sorted Antibody Secreting Cells (ASC) 5.29
SETDB1 compacts the inactive X chromosome in part through silencing an enhancer in the IL1RAPL1 gene 5.28
The LINC01138 Drives Malignancies via Activating Arginine Methyltransferase 5 in Hepatocellular Carcinoma 5.26
Long Non-coding RNA PICSAR Promotes Growth of Cutaneous Squamous Cell Carcinoma by Regulating ERK1/2 Activity 5.26
Highly-motile versus unsorted MDA-MB-231 breast cancer cells 5.2
Dynamic epigenetic remodeling underlies microRNA-mediated transdifferentiation of human adult fibroblasts into neuronal subtypes 5.19
Investigate A2M treatment on human prostate cancer xenograft in mice 5.13
Investigate A2M treatment on human prostate cancer and mouse liver 5.13
Modeling the MYC-driven normal-to-tumour switch in breast cancer. 5.12
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma (RNA-Seq) 5.1
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma 5.1
RNAseq of CD8+ and CD8- MAIT cells in human peripheral blood 5.07
Montelukast counteracts the influenza virus-induced block in unfolded protein stress response and reduces virus multiplication 5.05
To identify transcripts that are differentially expressed in the MYCN amplified vs MYCN non-amplified cell lines using Next Generation Sequencing 5.04
Effect in HCT116 cells of 3hr cortistatin A treatment on gene expression. 5.02
Mediator kinase inhibition further activates super-enhancer-associated genes in AML 5.02
U1 snRNP telescripting regulates size-function stratified human genome 4.99
Directed differentiation of human embryonic stem cells to corneal endothelial cell-like cells: A transcriptomic analysis 4.99
Effect of CHKA knockdown on C4-2 cell transcriptome 4.96
Ribosome queuing enables non-AUG translation to be resistant to multiple protein synthesis inhibitors 4.94
Identifying ASCL1 target genes in primary GBM stem cell cultures [RNA-seq] 4.94
Transcriptomic analyssis following EHMT1/2 inhibition 4.94
Widespread N6-methyladenosine-dependent RNA Structural Switches Regulate RNA-Protein Interactions 4.88
Transcriptomic analysis of senescent cells upon PTBP1 knockdown and EXOC7 knockdown 4.88
Obstructed defecation – an enteric neuropathy? An exploratory study of patient samples 4.84
MicroRNA (miR)-211 loss promotes metabolic vulnerability and BRAF inhibitor sensitivity in melanoma 4.83
3’READS+, a sensitive and accurate method for 3’ end sequencing of polyadenylated RNA 4.83
LSD1 mediates MYCN control of epithelial-mesenchymal transition through silencing of metastatic suppressor NDRG1 gene 4.79
LncRNA NONHSAT113026 represses renal cell carcinoma tumorigenesis through interacting with NF-κB/p50 and SLUG 4.79
Stochastic genome - nuclear lamina contacts are linked to histone H3K9 dimethylation 4.76
Stochastic genome - nuclear lamina contacts are linked to histone H3K9 dimethylation (RNA-seq data) 4.76
H3K27ac ChIP-Seq and mRNA-Seq analysis of five human B-lymphoblastoid cell lines (LCLs) prepared from the same healthy male individual (CEPH/UTAH). 4.74
RNA-seq of Human neck of femur (NOF) fracture hip and osteoarthritic (OA) cartilage 4.71
Long noncoding RNA ROCR contributes to SOX9 expression and chondrogenic differentiation of human mesenchymal stem cells 4.71
Cohesin and CTCF Differentially Affect the Chromatin Architecture and Gene Expression in Human Cells 4.7
Gene expression analysis of dengue-infected cells 4.7
RNA sequencing of CACO-2 cells incubated with bifidobacteria grown on human milk oligosaccharides. 4.68
The SPOP-containing Complex Functions as an E3 Ligase for SETD2 to Regulate Gene-Specific H3K36me3-Coupled Alternative Splicing 4.68
Loss of the Chr16p11.2 candidate gene QPRT leads to aberrant neuronal differentiation 4.65
Effects of NSUN2 deficiency on the mRNA 5-methylcytosine modification and gene expression profile in HEK293 cells (RNA-Seq) 4.62
Inhibitors of the histone methyltransferases EZH2/1 induce a potent antiviral state and suppress infection by diverse viral pathogens [RNA-Seq] 4.61
Inhibitors of the histone methyltransferases EZH2/1 induce a potent antiviral state and suppress infection by diverse viral pathogens 4.61
Cleavage Factor Im as a key regulator of 3’ UTR length 4.57
HOXC6 affects the malignant phenotype of esophageal squamous cell carcinoma cells 4.57
Inactivation of CFTR by CRISPR/Cas9 alters transcriptional regulation of inflammatory pathways and other networks 4.56
Ribosomal footprinting of MDA_Ctrl and MDA_Arg overexpression cell lines 4.55
Heterozygous and homozygous knock-in of PIK3CA-H1047R into human iPSCs 4.55
RNA-seq in LNCaP cell line overexpressing WT or mutant FOXA1 4.51
Forkhead domain mutations in FOXA1 drive prostate cancer cell progression 4.51
High-throughput sequencing of pluripotent cells 4.5
In Vitro and In Vivo Modulation of Alternative Splicing by the Biguanide Metformin. 4.48
The m 6 A-methylase complex recruits TREX and regulates mRNA export. 4.48
Ambient O2 pressure induces NF-kB1/RelA related inflammatory response in human lung epithelial cells in vitro 4.47
Targeted Apoptosis of Senescent Cells Restores Tissue Homeostasis in Response to Chemotoxicity and Aging 4.44
Gene expression signatures of innate lymphoid cells from human blood 4.43
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures 4.43
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures [RNA-Seq] 4.43
Gene Expression Analysis of Melanoma Cells Treated with 6-Thio-dG In Vitro 4.42
RNA-seq of YB5 cells treated with Proscillaridin A 4.41
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma 4.38
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma [RNA-seq] 4.38
Transcriptome-wide profiling of poly(A)-tail length, translation efficiency and mRNA stability using TED-seq, mRNA-seq, Ribo-seq and PRO-seq in ER stress conditions 4.36
Transcriptomic changes mediated by β-amyloid in human aortic endothelial cells (HAOEC) 4.36
Knock-down of Ror1 in MDA-MB-231 cell line decreases cell invasiveness 4.36
Controlling for gene expression changes in transcription factor protein networks. 4.35
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation I 4.35
RNA sequencing to study transcriptomic changes in DLD-1 (colorectal adenocarcinoma) cells exposed to soft polyacrylamide matrices (~2 kPa and ~55 kPa) for short time scale of 90 minutes 4.34
Gene expression profiling of LNCaP cells following shRNA-mediated knockdown of TMEFF2 and growth in presence and absence of dihydrotestosterone 4.31
Sequential regulatory loops as key gatekeepers for neuronal reprogramming in human cells 4.27
Sequential regulatory loops as key gatekeepers for neuronal reprogramming in human cells [RNA-seq] 4.27
Dual role of CSL (RBP-Jk) and NOTCH1 in CAF 4.25
Dual role of CSL (RBP-Jk) and NOTCH1 in cancer-associated fibroblast genome stability and expansion [RNA-seq] 4.25
Impact of ETV7 activity on interferon-stimulated gene expression in 293T cells treated with interferon alpha 4.21
ETV7 and interferon response 4.21
Single-cell transcriptome of human epithelial cells reveals novel insights into early innate immune responses to influenza virus and viral antagonism 4.21
X-Ray induced DNA-Hydroxymethylation changes 4.15
Small molecule inhibition of ERK dimerization prevents tumorigenesis by Ras-ERK pathway oncogenes 4.14
Maintaining iron homeostasis is the key role of lysosomal acidity for cell proliferation 4.09
Effect of FGF13 depletion on the H460 cell line 4.08
Gene expression profile of melanoma cell lines after overexpression or knockdown of KPC1 4.04
transcriptomic profiling of HEK293 cells upon individual knockdown of the splicing factors RBM17, U2SURP or CHERP 4.0
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer [RNA-seq] 3.98
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer 3.98
Small-molecule targeting of brachyury transcription factor addiction in chordoma [rnaseq_sgrna] 3.97
Systematic discovery of endogenous human ribonucleoprotein complexes 3.97
Evolving Spindlin1 Small Molecule Inhibitors Using Protein Microarrays 3.94
PRDM1 inhibits proliferation of human colon cancer organoids 3.94
Biosynthesis of histone messenger RNA employs a specific 3' end endonuclease 3.9
Transcriptome landscape of HeLa response upon triamcinolone acetonide 3.9
Effect of PDZ domain binding Kinase inhibition using TOPK-32 (called PBKi) on C4-2 cell transcriptome 3.9
DAOY-Notch1/Notch2 knockout: transcriptome comparison 3.88
Transcriptome analysis of human lung epithelial cells 3.83
RNA sequencing (RNA-SEQ) of Human endothelial cells (HUVEC) in LFS, sFRP2OE, and WT conditioned media 3.8
Identification of PRMT5-dependent genes in ESA+CD24lowCD44+ MCF7 cells 3.8
Transcriptional profile of human STAT1-/- fibroblasts expressing IFI6 or empty control vector 3.77
Illumina Total RNA-seq in HeLa 3.75
RNA-seq analysis of breast cancer 3.73
RNA-seq analysis and shRNA screen of breast cancer 3.73
LncRNA-dependent mechanisms of androgen receptor-regulated gene activation programs 3.7
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition [RNA-Seq] 3.68
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition. 3.68
METTL3 and WTAP 3.68
Nudt3 is a mRNA Decapping Enzyme That Modulates Cell Migration 3.67
NF-κB p65 dimerization and DNA-binding is important for inflammatory gene expression 3.67
GRHL2 is a key lineage determining factor which collaborates with FOXA1 to establish a targetable collateral pathway in the setting of endocrine therapy-resistant breast cancer (RNA-Seq data set 2) 3.66
Global host gene expression changes in KSHV+ PEL cells upon KSHV reactivation 3.65
3.64
RBM25 is a global splicing factor promoting inclusion of alternatively spliced exons 3.64
Metastasis in triple-negative breast cancer 3.64
Functional and genomic characterization of a xenograft model system for the study of metastasis in triple-negative breast cancer. 3.64
Identifying the molecular mode of action of itraconazole in colorectal cancer 3.63
Effect of CRISPR-Cas9 mediated knock-out of integrin alpha2 on the transcriptome of DU145 prostate cancer cell grown as a spheroid culture 3.6
Spatially Constrained Tandem Bromodomain Inhibition Bolsters Sustained Repression of BRD4 Transcriptional Activity for TNBC Cell Growth 3.56
Contribution of SRF and Nkx2-5 to androgen-dependent gene expression in prostate cancer 3.51
Seletive inhibition of CDK9 in DLBCL cell lines 3.46
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L 3.46
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with tcons_00001221 shRNA or control shRNA 3.45
The long non-coding RNA MALAT1 contributes to the pathogenesis of multiple sclerosis through alternative splicing and backsplicing regulation 3.45
A549 cell transcriptome responses to infection with H7N9 influenza virus 3.36
In vitro differentiation of human embryonic stem cells into ovarian follicle-like cells 3.34
Chemotherapeutic drugs inhibiting Topoisomerase 1 activity inhibit TNF-induced inflammatory gene expression 3.3
Impact of GDF15 expression of ovarian cancer cell on stroma and Cisplatin responses 3.29
Real-time observation of light-controlled transcription in living cells 3.27
Tracking transcriptional changes in a species-specific manner during experimental hepatoblastoma progression in vivo 3.25
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription 3.25
Bioreactor-engineered cancer tissues mimic phenotypes, gene expression profiles and drug resistance mechanisms detectable in xenografts and clinical specimens. 3.25
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 2] 3.19
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex 3.19
Transcriptome profiling of hnRNP A2/B1 and A1 depleted cells 3.19
RNA-Seq analysis of 4N and 2N RPE1 cells following polyploid induction via cytokinesis failure by siRNA knockdown of Anillin [tpo8] 3.18
mRNA-sequencing of 293T-no dice transfected with miR-16, miR-214, or KSHV-miR-K6-5p 3.14
Genome wide miR-191 target profile determined by RIP and gene expression profiling 3.11
miR-191 regulates human cell proliferation and directly targets multiple oncogenes [seq] 3.11
DDX54 regulates transcriptome dynamics during DNA damage response [RNA-seq2] 3.03
ATRX is necessary for cellular senescence and represses HRAS to drive cells from quiescence into senescence [RNA-Seq] 3.02
ATRX is necessary for cellular senescence and represses HRAS to drive cells from quiescence into senescence 3.02
Effect of from Human Umbilical Vein Endothelial Cells 2.95
HMGA1 and FOXM1 synergistically regulate a common gene network modulating angiogenesis in breast cancer 2.92
Epigenetic reprogramming of melanoma cells by vitamin C treatment 2.89
Host transcriptome analysis of Aspergillus fumigatus infection in Airway Epithelial Cells 2.89
FOXA1 Chromatin Binding is Regulated by LSD1-Mediated Demethylation 2.88
RNA-Seq with DHT induction and/or GSK treatment at 24, 48 hrs and 2 weeks 2.88
A non-catalytic function of carbonic anhydrase IX contributes to the glycolytic phenotype and pH regulation in human breast cancer cells 2.8
Targets of ROR2 overexpression in MCF-7 cells revealed a differentially regulated module of non-canonical WNT signaling pathway 2.8
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells (RNA-seq) 2.79
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells 2.79
Transcriptional profile of human STAT1-/- fibroblasts expressing LY6E or empty control vector 2.78
Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid. 2.77
Transcriptomic profiling of O-GlcNAcylated mRNA-protein complexes by using OG-CLAP in HeLa cells. 2.76
RNA-sequencing of the human milk fat layer during colostrum, transitional, and mature stages of lactation 2.72
Effect of low-dose sorafenib and alkylating agents in inflammation and angiogenesis in breast cancer 2.7
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer (RNA-seq) 2.69
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer 2.69
mRNA expression in human DAOY cells 2.69
FBP2 inhibits sarcoma progression by restraining mitochondrial biogenesis 2.66
PRMT5 Interacts with the BCL6 Oncoprotein and is Required for Germinal Center Formation and Lymphoma Cell Survival 2.65
Transcriptome of invasive mucinous adnocarcinoma of the lung and adjacent normal lung tissues from 6 patients based on RNA-seq method 2.57
Loss of Function Mutations in ETS2 Repressor Factor (ERF) Reveal a Balance Between Positive and Negative ETS Factors Controlling Prostate Oncogenesis [22PC RNA-seq] 2.55
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (ChIP-seq & RNA-seq datasets) 2.51
Genome-wide discovery of human splicing branchpoints 2.48
Huntingtin aggregation impairs autophagy leading to Argonaute-2 accumulation and global microRNA dysregulation 2.43
The flightless I protein is involved in the genome-wide mRNA post-transcriptional regulation in lung carcinoma cells 2.37
RNAseq of ribosomal fractionation to assess the effect of CBFB on translation regulation 2.36
The Hippo pathway kinase LATS1 scaffolds Beclin1 in autophagy regulation in hepatocellular carcinoma 2.32
PolyA+ RNA-seq in ALL-SIL upon TLX1 knockdown 2.3
RNA-seq of IL-4 stimulated human keratinocytes 2.29
Cooperation of dominant oncogenes with regulatory variants shapes clinical outcomes in pediatric cancer 2.29
RNA-seq of three Ewing sarcoma cell lines (A673, SK-N-MC, RDES), transfected with either siControl or siMYBL2. 2.29
RNA sequencing Facilitates Quantitative Analysis of luminal breast cancer cells and basal breast cancer cells Transcriptomes 2.29
Expression profiling of MCF-7 cells with 10nM treatment of TCDD 2.27
Expression profiling of MCF-7 cells with treatment of TCDD 2.27
NOTCH signaling is activated in and contributes to resistance in enzalutamide-resistant prostate cancer cells 2.27
RNA-sequencing of mRNAs from control and CAP-D3 deficient Salmonella infected HT-29 cells 2.27
hnRNP L protects mRNAs from nonsense-mediated mRNA decay 2.26
LncPRESS1 is a p53-regulated lncRNA that safeguards pluripotency by disrupting SIRT6 mediated de-acetylation of histone H3K56 2.26
Altered mRNA splicing by mutant p53 activates oncogenic RAS in pancreatic cancer 2.24
RNA-sequencing of tamoxifen-resistant and -sensitive breast cancer cell lines. 2.21
Gene expression profile of HGC27 gastric cancer cell p53 KO and KD 2.2
Suppression of NAF-1 in Breast Cancer Cells Reduces their Tumorigenicity by Interfering with Cellular Iron Distribution and Metabolism and Ensuing ROS Formation and Apoptosis 2.14
RNA deep sequencing analysis of human brain microvascular endothelial cells (ECs) treated with glioma-conditioned medium (glioma-CM) 2.09
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [SLAM-Seq] 2.07
RNA-sequencing analysis of glucose and acetate regulated transcripts in glioblastoma cells 2.07
An optimization system for isolating and sequencing of single human colon cancer cells 2.05
microRNA-seq and RNA-seq reveals changes in the astrocyte transcriptome following Borrelia burgdorferi infection 2.05
RNA-seq reveals changes in the astrocyte transcriptome following Borrelia burgdorferi infection 2.05
Human MAIT cells exit peripheral tissues and re-circulate via lymph in steady state conditions 2.03
RNA-Seq analysis of Head and Neck Squamous cell carcinoma cell-lines 2.02
Activating Transcription Factor 4 modulated TGFb-induced aggresiveness in triple negative breast cancer vis SMAD2/3/4 and mTORC2 signaling 1.99
YTHDF1 Amplifies Wnt/β-Catenin Signaling to Promote Intestinal Stemness 1.96
KLF6-dependent transcription in renal cancer cells 1.86
Tissue-resident memory T cells mediate immune homeostasis in the human pancreas through the PD-1/PD-L1 pathway 1.86
Cap-specific terminal N6-methylation of RNA by an RNA polymerase II-associated methyltransferase. 1.83
LncRNA-dependent mechanisms of androgen receptor-regulated gene activation programs [GRO-seq II] 1.82
Drug combination of 17-AAG and Belinostat on MDA-MB-231 breast cancer cells 1.81
Fusion discovery in breast cancer cell line 1.8
ELAVL2-regulated transcriptional networks in human neurons link atlernative splicing, autism and human neocortical evolution 1.8
RNA-seq of HEK293T cells overexpressing TET1-FL or TET1-ALT 1.79
Multi-omic measurements of heterogeneity in HeLa cells across laboratories 1.72
Isolation and Functional Interrogation of Adult Human Prostate Epithelial Stem Cells at Single Cell Resolution 1.7
RNA-Seq analysis of prostate cancer cell line LNCaP treated with vehicle, androgen, androgen and IMTPPE, androgen and JJ-(+)-450, androgen and JJ-(-)450, androgen and enzalutamide 1.65
Ribosome profiling upon inhibition of eIF4A 1.65
Activin/Smad2-induced H3K27me3 reduction is crucial to initiate mesendoderm differentiation of ES Cells 1.64
Transcriptome wide identification of retained introns upon depletion of the splicing factors SNW1 or PRPF8 1.58
A SRp55-regulated alternative splicing network controls pancreatic beta cell survival and function 1.57
Transient stabilization, rather than inhibition of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphoma 1.57
ADAR1-editing of cellular and measles virus-derived duplex RNA 1.57
ADAR1-editing in HeLa, p150-KO and ADAR1-KO transcriptomes 1.57
Interaction between mitoNEET and NAF-1 in cancer cells 1.55
Comparative Analysis of Cas9 Activators Across Multiple Species 1.55
RNA editing in nascent RNA affects pre-mRNA splicing 1.51
4sUDRB-seq: measuring transcription elongation and initiation genomewide 1.5
RNA:DNA hybrids in the human genome have distinctive nucleotide characteristics, chromatin composition, and transcriptional relationships (RNA-seq) 1.47
RNA:DNA hybrids in the human genome have distinctive nucleotide characteristics, chromatin composition, and transcriptional relationships 1.47
Function and hormonal regulation of GATA3 in human first trimester placentation 1.43
Ribosomal protein RPL26 is the principal target of UFMylation 1.42
RNAseq of cell lines with knocked in ESR1 mutations 1.42
Transcriptome of human ILC2s; primary vs IL-1b-primed 1.38
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer 1.38
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer [RNA-Seq] 1.38
Next generation sequencing of advanced non-castrate prostate cancer treated with docetaxel chemotherapy 1.37
CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary (I) 1.36
Transcriptomic analysis of differential expressed genes of human tonsillar epithelial cells UT-SCC-60B in response to EV71 infection 1.36
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HEK293 cells treated with or without TNF-alpha 1.35
Next generation sequencing of the transcriptome in MCF-7 cells with/without SRA knockdown 1.32
The ARID1A tumor suppressor controls global transcription via pausing of RNA Polymerase II 1.3
RNA-Seq with and without RNase treatment in PCa cell lines 1.26
EZH1/SUZ12 complex positively regulates the transcription of NF-κB target genes via interaction with UXT 1.26
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-Seq KO] 1.23
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo 1.18
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo [RNA-Seq] 1.18
Acquired resistance to MEK-CDK4/6 inhibitor combinations in cutaneous melanoma 1.16
Small-molecule targeting of brachyury transcription factor addiction in chordoma [rnaseq_compound] 1.16
Elongation Factor TFIIS Prevents Transcription Stress and R-Loop Accumulation to Maintain Genome Stability 1.15
Elongation Factor TFIIS Prevents Transcription Stress and R-Loop Accumulation to Maintain Genome Stability [ RNA-seq] 1.15
RING-finger protein 6 amplification activates JAK/STAT3 pathway by modifying SHP-1 ubiquitylation and associates with poor outcome in colorectal cancer 1.14
CNOT1 and Transcriptomic Landscape of a HeLa Cell Line 1.13
RNA expression profiles from HUVECs overexpressing adenovirally delivered HIF1a and HIF2a proteins 1.09
Translating transcriptome of cancer cells in situ in mesenchymal-rich tumor microenvironment 1.08
Global unleashing of transcription elongation waves in response to genotoxic stress restricts somatic mutation rate 1.07
Disruption of the TFAP2A regulatory domain causes Branchio-Oculo-Facial Syndrome (BOFS) and illuminates pathomechanisms for other human neurocristopathies [RNA-seq data set 2] 1.05
ZNF599 and DNMT3A coordinately control nuclear envelope organization by repression of SUN4 expression 1.05
Gene expression profiling by RNA-seq of SW480 TGM2 knockdown cells 1.04
Structural basis for human respiratory syncytial virus NS1-mediated modulation of host responses 1.0
Gene expression profiling of patient's DCIS-IDC tandem lesions by RNA sequencing analysis 0.91
An intramolecular salt bridge linking TDP43’s RNA recognition motifs dictates RNA binding, protein stability and TDP43-dependent neurodegeneration 0.88
Functional significance of the HIV-1 Tat signature amino acid residues 0.88
Downregulation of LATS kinases alters p53 to promote cell migration 0.87
Transposon-based construction of strand-specific RNA-seq libraries 0.87
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates [RNA-seq] 0.82
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates 0.82
Expression data for HT29 cells treated with 5-aza-deoxy-cytidine [RNA-Seq] 0.8
Expression data for HT29 cells treated with 5-aza-deoxy-cytidine 0.8
mRNA sequencing identifies differential gene expresssion profiles between ASCC3 knock-down cells and control cells 0.75
DNMT1-associated long non-coding RNA regulate global gene expression and DNA methylation in colon cancer 0.72
Regulation of hypoxia-inducible factor activity by ZMYND8 0.71
Effect of nuclear IL-33 on gene expression 0.71
RNA G-quadruplexes mark repressive upstream open reading frames in human mRNAs 0.61
T47D xenografts treated with various combinations of ER- and PR-targeting therapies 0.6
Activation of the p53 transcriptional program sensitizes cancer cells to Cdk7 inhibitors 0.58
MCF-7 as a model for functional analysis of breast cancer risk variants 0.58
Adenovirus Small E1A Employs the Lysine Acetylases p300/CBP and Tumor Suppressor Rb to Repress Select Host Genes and Promote Productive Virus Infection [RNA-seq] 0.57
Adenovirus Small E1A Employs the Lysine Acetylases p300/CBP and Tumor Suppressor Rb to Repress Select Host Genes and Promote Productive Virus Infection 0.57
Sirt6 Oncogene Mediates PI3K/Akt Signaling Activation in Diffuse Large B-Cell Lymphoma 0.57
GRHL2 is a key lineage determining factor which collaborates with FOXA1 to establish a targetable collateral pathway in the setting of endocrine therapy-resistant breast cancer (RNA-Seq data set 1) 0.55
Identification of Resistance Genes to BRAF Inhibitor in Melanoma by piggyBac Transposon Activation Mutagenesis Screen 0.55
A novel transcriptional network for the Androgen Receptor in human epididymis epithelial cells [RNA-Seq] 0.54
A novel transcriptional network for the Androgen Receptor in human epididymis epithelial cells 0.54
RNA-Sequencing approach for the identification of novel long non-coding RNA biomarkers in colorectal cancer 0.52
RNA sequencing of prostate cancers reveal insights on the prognostic significance of visibility on multi-parametric MRI 0.51
Pseudouridylation of tRNA-derived fragments steers translation control in stem cells [Polysome-Seq] 0.47
Single-cell RNA-seq reveals differentiation of bona fide human pDCs and cDC1s in cultures of cord blood CD34+ progenitors, and a newly identified terminal differentiation step of cDC1s 0.47
Disease-associated mutation in SRSF2 misregulates splicing by altering RNA binding affinities 0.45
Paxillin regulates genomic networks in prostate cancer [PC3] 0.43
Tracing Enhancer Networks using Epigenetic Traits (TENET) 0.41
Transcriptomic Analysis Of circRNAs/miRNAs/mRNAs upon Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection 0.41
Transcriptome-profiling (RNA-seq) and Ribosome-profiling (Ribo-seq) in proliferation, quiescence, senescence and transformed states. 0.4
Genome-wide DNA hypomethylation and RNA:DNA hybrid accumulation in Aicardi-Goutières syndrome 0.4
Next Generation Sequencing Quantitative Analysis of Wild Type and AML1-ETO Related Fusion Circular RNA (F-CircAE) Knockdown Kasumi-1 Cells Transcriptomes 0.4
Macrophages redirect phagocytosis by non-professional phagocytes and influence inflammation 0.38
Single-cell Transcriptomics reveals multi-step adaptations to endocrine therapy 0.37
Differential YAP expression in glioma cells induces cell competition and promotes tumorigenesis 0.37
Exploiting Prmt5-orchestrated intron detention signatures to treat splicing-addicted malignant glioma tumors 0.37
Transcriptomic profiling of sequential tumours from breast cancer patients provides a global view of metastatic expression changes following endocrine therapy 0.36
Iron response of HepG2 cells 0.35
transcriptome studies of BRD4 inhibitor BDF-1253 on renal clear carcinoma 786-O cells 0.34
Transcriptome-wide off-target RNA editing induced by CRISPR-guided DNA base editors [Modifications - screen] 0.32
Maternal-biased H3K27me3 correlates with paternal-specific gene expression in the human morula 0.32
Genome-wide profile of cJun and p27 and gene expression profile in breast cancer cells 0.32
Gene expression profile in breast cancer cells 0.32
Transcription factors and stress response gene alterations in human keratinocytes following Solar Simulated Ultra Violet Radiation 0.3
Interphase condensins regulate ligand-depedent enhancer activation 0.29
Interphase condensins regulate ligand-depedent enhancer activation (GRO-seq) 0.29
Transcriptional profiling of growing and senescent WT and IL-1R-depleted IMR90 cells 0.29
WNT signaling memory is required for ACTIVIN to function as a morphogen 0.29
CD8+ T cells regulate tumor ferroptosis during cancer immunotherapy 0.29
KAP1 regulates ERVs in differentiated human cells and contributes to innate immune control 0.29
eRNA: A graphic user interface-based tool for RNA sequencing data analysis 0.28
H1609088 Human RNA-Sequencing 0.26
Genome-wide hsa-miR-503, hsa-miR-103, and hsa-miR-494 target profiles 0.24
hsa-miR-503, hsa-miR-103, and hsa-miR-494 genome wide target profiles [RNA-Seq and RIP-Seq] 0.24
Systematic analysis of gene expression profiles controlled by hnRNP Q and hnRNP R, two closely related human heterogeneous nuclear ribonucleoproteins. 0.24
RNA deep sequencing analysis of glioma stem cells(GSCs) and non-GSCs 0.24
Functional genomic analysis of the haploinsufficient tumor suppressor, CUX1 0.23
β-Caryophyllene Enhances the Transcriptional Upregulation of SREBP-dependent Lipid Biosynthesis in Breast Cancer Cells 0.23
RNAseq of Breast cancer PDX samples 0.23
Pancreatic Beta Cell Enhancers Regulate Rhythmic Transcription of Exocyst Triggering and Diabetes 0.22
Genome-wide Circadian Control of Transcription at Active Enhancers Regulates Insulin Secretion and Diabetes Risk 0.22
RNA sequencing from FOXM1 knockout HEK293T cells reconstituted with FOXM1 isoforms a, b and c. 0.19
Metabolism as an early predictor of DPSCs aging 0.16
Canonical and non-canonical regulatory roles of androgen receptor variant 7 in prostate cancer 0.15
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML [RNA-Seq human] 0.13
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML 0.13
The Small Molecule ISRIB Reverses the Effects of eIF2α Phosphorylation on Translation and Stress Granule Assembly 0.12
CRISPR-Cas9 based screen for p53-bound enhancers that function in oncogene-induced senescence 0.11
Transcriptomic analysis of the effect of histone H4 K31R mutation in U2OS cells 0.08
Transcriptome analysis of V336Y mutant mitochondrial ribosomal protein in human HEK293 cell line 0.08
Immunophenotyping and Transcriptomic Outcomes in PDX-Derived TNBC Tissue 0.06
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (TLR perturbation Bulk RNA-Seq) 0.06
Identification of a unique gene expression signature in mercury and 2,3,7,8-tetrachlorodibenzo-p-dioxin co-exposed cells 0.06
Targeting Spt5-Pol II small-molecule inhibitors uncouple distinct activities and reveal additional regulatory roles 0.03
The RNA binding protein IGF2BP3 promotes hematopoietic progenitor cell proliferation by targeting leukemogenic pathways 0.02
Transcriptomic analysis to underly the heterogeneity between 4 cellular models derived from patients diagnosed with pediatric high-grade gliomas under controlled atmosphere (modulation of oxygen level). 0.02
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 1] 0.02
Activation Dynamics and Immunoglobulin Evolution of Pre-existing and Newly Generated Human Memory B-cell Responses to Influenza Hemagglutinin 0.01
Hsa-miR-371a-5p and hsa-miR-518a-3p regulated genes in choriocarcinoma cells 0.01
Genome-wide analysis of the Integrator complex 0.0
Genome-wide analysis of the Integrator complex (HTS) 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation